Stuart Randle - Teleflex Incorporated Independent Director
| TFX Stock | USD 190.64 3.21 1.71% |
Director
Mr. Stuart Allen Randle serves as Independent Director of Teleflex Inc. Mr. Randle was a director of Teleflex since 2009 and currently serves as chair of the Nominating and Governance Committee and as a member of the Compensation Committee. Mr. Randle retired in December 2018 after serving for three years as the Chief Executive Officer of Ivenix, Inc., a medical device company that provides infusion delivery systems. Previously, Mr. Randle had been retired since September 2014 after serving for 10 years as President and Chief Executive Officer of GI Dynamics, Inc., a medical device company. From 2003 to 2004, he served as Interim Chief Executive Officer of Optobionics Corporationrationration, a medical device company. From 2002 to 2003, Mr. Randle held the position of Entrepreneur in Residence of Advanced Technology Ventures, a healthcare and information technology VC firm. From 1998 to 2001, he was President and Chief Executive Officer of Act Medical, Inc. Prior to 1998, Mr. Randle held various senior management positions with Allegiance Healthcare Corporation and Baxter International Inc. Mr. Randle currently serves as a director of Beacon Roofing Supply, Inc. and Flex Pharma, Inc. Mr. Randles medical device company experience, coupled with past senior management positions at medical device companies, enables him to provide valuable insights regarding a variety of business, management and technical issues. since 2009.
| Age | 61 |
| Tenure | 15 years |
| Address | 550 East Swedesford Road, Wayne, PA, United States, 19087-1603 |
| Phone | 610-225-6800 |
| Web | https://www.teleflex.com |
Stuart Randle Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stuart Randle against Teleflex Incorporated stock is an integral part of due diligence when investing in Teleflex Incorporated. Stuart Randle insider activity provides valuable insight into whether Teleflex Incorporated is net buyers or sellers over its current business cycle. Note, Teleflex Incorporated insiders must abide by specific rules, including filing SEC forms every time they buy or sell Teleflex Incorporated'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stuart Randle over three months ago Disposition of 2674 shares by Stuart Randle of Teleflex Incorporated at 121.0 subject to Rule 16b-3 |
Teleflex Incorporated Management Efficiency
The company has Return on Asset of 0.0315 % which means that on every $100 spent on assets, it made $0.0315 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0541 %, implying that it generated $0.0541 on every 100 dollars invested. Teleflex Incorporated's management efficiency ratios could be used to measure how well Teleflex Incorporated manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Teleflex Incorporated's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.06 in 2024, whereas Return On Capital Employed is likely to drop 0.07 in 2024. At this time, Teleflex Incorporated's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 6.4 B in 2024, whereas Total Current Assets are likely to drop slightly above 892.1 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Giovanna Monnas | AptarGroup | 65 | |
| Marshall Larsen | Becton Dickinson and | 72 | |
| Deborah Tanner | West Pharmaceutical Services | 57 | |
| Andreas Kramvis | AptarGroup | 68 | |
| Charles Dockendorff | Haemonetics | 66 | |
| William Feehery | West Pharmaceutical Services | 50 | |
| Gary Petersmeyer | The Cooper Companies, | 73 | |
| Mark Buthman | West Pharmaceutical Services | 60 | |
| Colleen Jay | The Cooper Companies, | 58 | |
| Paolo Pucci | West Pharmaceutical Services | 59 | |
| Rebecca Rimel | Becton Dickinson and | 69 | |
| Maria Rivas | The Cooper Companies, | 57 | |
| Joanne Smith | AptarGroup | 59 | |
| Bertram Scott | Becton Dickinson and | 69 | |
| Douglas Michels | West Pharmaceutical Services | 63 | |
| Jeffrey Henderson | Becton Dickinson and | 56 | |
| Karen Drexler | ResMed Inc | 60 | |
| Christopher Jones | Becton Dickinson and | 65 | |
| Arthur MD | Alcon AG | 62 | |
| Timothy Ring | Becton Dickinson and | 63 | |
| Mark Kroll | Haemonetics | 67 | |
Management Performance
| Return On Equity | 0.0541 | ||||
| Return On Asset | 0.0315 |
Teleflex Incorporated Leadership Team
Elected by the shareholders, the Teleflex Incorporated's board of directors comprises two types of representatives: Teleflex Incorporated inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Teleflex. The board's role is to monitor Teleflex Incorporated's management team and ensure that shareholders' interests are well served. Teleflex Incorporated's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Teleflex Incorporated's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, Executive CFO | ||
| Michelle Fox, Corporate Officer | ||
| Roger Graham, President Interventional | ||
| Timothy Duffy, VP Officer | ||
| John Heinmiller, Independent Director | ||
| John CFA, VP Relations | ||
| Andrew Krakauer, Independent Director | ||
| Howard Cyr, Corporate Officer | ||
| Liam Kelly, Chairman of the Board, President, Chief Executive Officer | ||
| Matthew James, EMEA President | ||
| Stephen Klasko, Independent Director | ||
| George Babich, Lead Independent Director | ||
| Matt Tomkin, VP Devel | ||
| Jake Newman, President Americas | ||
| Daniel JD, General VP | ||
| James Leyden, Corporate Vice President, General Counsel, Secretary | ||
| Thomas Powell, Chief Financial Officer, Executive Vice President | ||
| Cameron Hicks, Corporate Vice President - Human Resources and Communications | ||
| Mario Wijker, Corporate Vice President - Quality Assurance and Regulatory Affairs | ||
| Jay White, Corporate Vice President and President Global Commercial | ||
| Karen Boylan, Vice President - Global Strategic Projects | ||
| James Winters, Corporate Vice President - Manufacturing and Supply Chain | ||
| James Ferguson, President Surgical | ||
| John Deren, Chief Accounting Officer, Vice President | ||
| Candace Duncan, Independent Director | ||
| Richard Packer, Independent Director | ||
| Praneet Mehrotra, President APAC | ||
| Stuart Randle, Independent Director | ||
| Lisa Kudlacz, President Vascular | ||
| Gretchen Haggerty, Independent Director | ||
| Daniel Logue, Corporate Vice President General Counsel and Secretary |
Teleflex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Teleflex Incorporated a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0541 | ||||
| Return On Asset | 0.0315 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 10.47 B | ||||
| Shares Outstanding | 46.44 M | ||||
| Shares Owned By Insiders | 0.28 % | ||||
| Shares Owned By Institutions | 99.61 % | ||||
| Number Of Shares Shorted | 658.28 K | ||||
| Price To Earning | 38.28 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Teleflex Stock Analysis
When running Teleflex Incorporated's price analysis, check to measure Teleflex Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teleflex Incorporated is operating at the current time. Most of Teleflex Incorporated's value examination focuses on studying past and present price action to predict the probability of Teleflex Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teleflex Incorporated's price. Additionally, you may evaluate how the addition of Teleflex Incorporated to your portfolios can decrease your overall portfolio volatility.